Data was released from Krakow Poland at the International Meeting on the use of Autologous Growth Factors in Orthopaedics and Sports Medicine: "State of the Art" - Krakow, Poland - 24 April 2009. The study found that patients receiving cortisone showed a 40% improvement compared to PRP 75% at 12 months. This is the first head to head study. Cortisone is well known to carry a risk of weakening & rupturing a tendon & is often discouraged.
http://www.shoulderdoc.co.uk/article.asp?article=1323
We are conducting a multicenter FDA approved trial on tennis elbow beginning Mid June 2009.
www.orthohealing.com
No comments:
Post a Comment